Risks and benefits of omega 3 fats: Summary of responsesBMJ 2006; 332 doi: http://dx.doi.org/10.1136/bmj.332.7546.915-b (Published 13 April 2006) Cite this as: BMJ 2006;332:915
- Birte Twisselmann, assistant editor (web)
EDITOR—The systematic review by Hooper et al with accompanying editorial by Brunner resulted in 30-odd electronic responses, most of which raised similar concerns.1 2 The main issue was the selection of studies—an “indiscriminate” mix of primary and secondary prevention studies.
The main objection was to the inclusion of the “methodologically poor” DART-2 study,3 which alone changed the conclusion of the meta-analysis from “clear benefit” to “no benefit.” Among the numerous weaknesses that the DART-2 authors themselves had originally drawn attention to, were that this study was …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial